Method Article

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

DOI:

10.3791/68921

December 30th, 2025

* These authors contributed equally

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Hs578T breast cancer cells harboring the p53 V157F mutation exhibit significantly higher Thioflavin T fluorescence compared to MCF7 cells, indicating enhanced protein aggregation. Multipoint fluorescence measurements improve detection accuracy and reliability in identifying β-sheet-rich aggregates, underscoring the importance of aggregation-prone p53 mutations in cancer research and the development of therapeutic strategies.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The tumor suppressor p53, encoded by the TP53 gene, plays a central role in maintaining genomic stability. TP53 mutations, particularly hotspot variants, are found in approximately 50% of human cancers and may lead to the loss of tumor-suppressive functions or the acquisition of gain-of-function properties, including aggregation into prion-like structures.

In this study, we assessed the aggregation tendency of the p53 V157F mutation in Hs578T breast cancer cells compared to MCF7 cells expressing wild-type p53. Protein aggregation was evaluated using Thioflavin T (ThT) staining followed by fluorescence quantification in 96-well plate assays. Cells were stained with a ThT/Hoechst solution, washed, and analyzed using a microplate reader under defined excitation/emission parameters. Quantitative analysis using both single-point and four-point fluorescence readings revealed that Hs578T cells exhibited a 3.20- to 4.26-fold increase in ThT fluorescence intensity relative to MCF7, indicating significantly elevated levels of β-sheet-rich or amyloid-like aggregates. Multipoint measurements confirmed the widespread and consistent presence of protein aggregates across the well surface. These findings support the use of multipoint plate-reading to accurately detect protein aggregation in cell-based assays.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The TP53 gene, which encodes the tumor suppressor protein p53, is mutated in approximately 50% of human cancers1,2. Such mutations not only abolish the tumor-suppressive functions of p53 but, in certain hotspot variants, also promote the formation of prion-like aggregates3,4. These aggregated forms of mutant p53 frequently acquire gain-of-function properties, including increased resistance to anticancer therapies5,6. Therefore, identifying which p53 hotspot mutations are prone to aggre....

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

1. Cell seeding

  1. To assess cell viability, mix 10 µL of Trypan Blue with 10 µL of resuspended cells in 1x Dulbecco's Phosphate-Buffered Saline (DPBS) in a microcentrifuge tube and mix thoroughly.
  2. Load 10 µL of the mixture onto a counter slide, then count the live cells using an automated cell counter.
  3. Based on the viability count, seed 30,000 viable cells per well into a 96-well culture plate, with one well designated as a non-stained control and the remaining three wells used for staining.

2. Incubation

  1. Place the culture plate in a CO2 incubator ....

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

To investigate the presence of β-sheet-rich protein aggregates in breast cancer cells, MCF7 and Hs578T cell lines were subjected to ThT staining followed by fluorescence quantification. As shown in Figure 1, cells were seeded into four wells of a 96-well plate, with one well designated as an unstained control. The remaining three wells were stained with ThT according to the standard protocol. Fluorescence was measured using two approaches: (1) a single-point reading taken from the center of .......

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

When seeding cells into 96-well plates, it is often difficult to achieve uniform distribution across the well surface, as gently shaking or tapping the plate to spread the cells is not always feasible. This uneven distribution can introduce variability in signal intensity across the well. Multipoint fluorescence reading revealed significant variation between different regions within the same well, highlighting this bias and the potential for misleading results when only a single point is measured. Relying on a single cen.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors have no conflicts of interest to declare.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors gratefully acknowledge the technical assistance provided by the Basic Medical Core Laboratory at the College of Medicine, I-Shou University. This work was supported by grants from E-DA Hospital [EDAHJ114001 to C.-C.C.] and National Science and Technology Council, Taiwan [NSTC 112-2813-C-214-032-B to B.-H. C]

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
96-well culture plateSimplyPC396-0100
counter slideInvitrogenC10228
Countess II FL Automated Cell CounterThermo Fisher Scientific AMQAF1000
dPBSSimplyCC704-0500
Eppendorf tubeSimplyPC101-5000
Hoechst 33342AAT Bioquest17530
SpectraMax iD3Molecular Devices735-0391 
Thioflavin TSigma-AldrichT3516
Trypan BlueInvitrogenT10282

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Binayke, A., Mishra, S., Suman, P., Das, S., Chander, H. Awakening the "guardian of genome": Reactivation of mutant p53. Cancer Chemother Pharmacol. 83 (1), 1-15 (2019).
  2. Chen, C. C., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

P53 AggregationThioflavin T StainingProtein Aggregation DetectionMultipoint FluorescenceTP53 MutationAmyloid AggregatesMicroplate ReaderHs578T CellsFluorescence Quantification

Related Articles